Open AccessTo Assess the Prevalence of Cognitive Impairment in Type II Diabetes Mellitus: An Observational Study
Author(s) -
Shivani D. Godhasara,
Vaishali Suthar
Publication year - 2021
Publication title -
international journal of health sciences and research
Language(s) - English
Resource type - Journals
ISSN - 2249-9571
DOI - 10.52403/ijhsr.20211136
Subject(s) - medicine , montreal cognitive assessment , diabetes mellitus , dementia , type 2 diabetes mellitus , cognitive impairment , cognition , type 2 diabetes , disease , guideline , observational study , physical therapy , pediatrics , psychiatry , endocrinology , pathology
Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia that affects various body systems. Elevated blood glucose levels cause brain malfunction, sorbitol which damages blood vessels, and degeneration of the nerves that can lead to dementia or cognitive impairment. Cognitive impairment can result in nonadherence of patients to diabetes treatment, such as medication, diet and exercise.Purpose: The purpose of this study was to assess the prevalence of cognitive impairment in type II diabetes mellitus. Methodology: 50 participants of age group 30 - 60 years, both male and female were included in this study. Cognitive impairment was assessed with the English version of the Montreal Cognitive Assessment (MoCA) tool. The MoCA scoring according to Dementia and Driving Safety: A clinical guideline, Version 3, 2014.Result: Among the 50 patients who were assessed, 24 (48%) were cognitively impaired. 20 (40%) of the subjects were age group of 51-60 years, and males participants 11(22%) outnumbered females 9 (18%). The majority of patients (40%) had diabetes type II for < 2 years.Conclusion: There was strong correlation found between Type II DM and cognitive impairment.Key words: Prevalence, Cognitive impairment, Diabetes mellitus Type II, Montreal Cognitive assessment (MoCA).